Your browser doesn't support javascript.
loading
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
André, Fabrice; Hee Park, Yeon; Kim, Sung-Bae; Takano, Toshimi; Im, Seock-Ah; Borges, Giuliano; Lima, Joao Paulo; Aksoy, Sercan; Gavila Gregori, Joaquin; De Laurentiis, Michelino; Bianchini, Giampaolo; Roylance, Rebecca; Miyoshi, Yasuo; Armstrong, Anne; Sinha, Rajni; Ruiz Borrego, Manuel; Lim, Elgene; Ettl, Johannes; Yerushalmi, Rinat; Zagouri, Flora; Duhoux, Francois P; Fehm, Tanja; Gambhire, Dhiraj; Cathcart, Jillian; Wu, Cai; Chu, Changan; Egorov, Anton; Krop, Ian.
Afiliação
  • André F; Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
  • Hee Park Y; Samsung Medical Center, Seoul, South Korea.
  • Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Takano T; The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Borges G; Clínica de Neoplasias Litoral, Itajaí, Brazil.
  • Lima JP; AC Camargo Cancer Center, São Paulo, Brazil.
  • Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Türkiye.
  • Gavila Gregori J; Instituto Valenciano de Oncologia, Valencia, Spain.
  • De Laurentiis M; Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Naples, Italy.
  • Bianchini G; San Raffaele Hospital, Milan, Italy.
  • Roylance R; University College London Hospital, London, UK.
  • Miyoshi Y; Hyago College of Medicine University Hospital, Hyogo, Japan.
  • Armstrong A; The Christie Hospital, Manchester, UK.
  • Sinha R; Piedmont Cancer Institute, Atlanta, GA, USA.
  • Ruiz Borrego M; Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Lim E; St Vincent's Hospital Sydney, Sydney, NSW, Australia.
  • Ettl J; Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
  • Yerushalmi R; Rabin Medical Center-Beilinson Campus, Tel-Aviv University, Tel-Aviv, Israel.
  • Zagouri F; Alexandra General Hospital, Athens, Greece.
  • Duhoux FP; Cliniques universitaires Saint-Luc, Brussels, Belgium.
  • Fehm T; Universitaetsklinikum Düsseldorf, Düsseldorf, Germany.
  • Gambhire D; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Cathcart J; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Wu C; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Chu C; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Egorov A; Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Krop I; Yale Cancer Center, New Haven, CT, USA. Electronic address: ian.krop@yale.edu.
Lancet ; 401(10390): 1773-1785, 2023 05 27.
Article em En | MEDLINE | ID: mdl-37086745
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Neoplasias da Mama / Imunoconjugados Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Neoplasias da Mama / Imunoconjugados Idioma: En Ano de publicação: 2023 Tipo de documento: Article